Early Palliative Care for Patients With Advanced Pancreatic Cancer.

NCT04632303 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 250

Last updated 2025-09-12

No results posted yet for this study

Summary

Pancreatic adenocarcinoma is one of the deadliest cancers. Patients with pancreatic cancer experience marked physical suffering, psychological distress and resource-demanding care at the end-of-life. Therefore, an urgent need exists to evaluate the early specialized palliative care model in a comparative study and across multiple care settings to define quality of life and survival benefits in patients with pancreatic cancer.

Conditions

Interventions

OTHER

Early Palliative Care

Baseline palliative care visit Palliative care visits/calls at least every 4 weeks throughout life and additionally upon request Referral to exercise training Referral to nutritional specialist

Sponsors & Collaborators

  • Bispebjerg Hospital

    collaborator OTHER
  • Rigshospitalet, Denmark

    collaborator OTHER
  • Hvidovre University Hospital

    collaborator OTHER
  • Odense University Hospital

    collaborator OTHER
  • Aalborg University Hospital

    collaborator OTHER
  • Aarhus University Hospital

    collaborator OTHER
  • Vejle Hospital

    collaborator OTHER
  • Zealand University Hospital

    collaborator OTHER
  • Hillerod Hospital, Denmark

    collaborator OTHER
  • Herning Hospital

    collaborator OTHER
  • Inna Chen, MD

    lead OTHER

Principal Investigators

  • Mette Nissen, MD · Herlev & Gentofte Hospital

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-23
Primary Completion
2024-11-07
Completion
2026-11-30

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04632303 on ClinicalTrials.gov